drugset / Trial / NCT01695187

NB-001 Treatment of Recurrent Herpes Labialis

NCT01695187 ↗

Phase 3 Unknown 362 enrolled NanoBio Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study to test the hypothesis that time to healing of a cold sore will be lower in the active treatment arm of the study when compared to the vehicle (placebo). Subjects with a history of cold sores will be enrolled and administered active treatment or placebo in a blinded manner. Subjects will then be followed to assess time to healing.

Timeline

Start
2012-10
Primary completion
2013-06
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject NB-001 Other / unclassified 0.3 % Topical

Indications